Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women.
Perrella J, Berco M, Cecutti A, Gerulath A, Bhavnani BR.
Lipids Health Dis. 2003 Jun 20;2:4.
PMID: 12848896 [PubMed]
Related Articles Free article in PMC | at journal site
Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Bhavnani BR, Cecutti A, Gerulath A, Woolever AC, Berco M.
Menopause. 2001 Nov-Dec;8(6):408-19.
PMID: 11723413 [PubMed - indexed for MEDLINE]
Related Articles
Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
Bhavnani BR.
J Steroid Biochem Mol Biol. 2003 Jun;85(2-5):473-82. Review.
PMID: 12943738 [PubMed - indexed for MEDLINE]
Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death.
Berco M, Bhavnani BR.
J Soc Gynecol Investig. 2001 Jul-Aug;8(4):245-54.
PMID: 11525901 [PubMed - indexed for MEDLINE]
Equine estrogens differentially prevent neuronal cell death induced by glutamate.
Bhavnani BR, Berco M, Binkley J.
J Soc Gynecol Investig. 2003 Jul;10(5):302-8.
PMID: 12853093 [PubMed - indexed for MEDLINE]
Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women.
Zago V, Sanguinetti S, Brites F, Berg G, Verona J, Basilio F, Wikinski R, Schreier L.
Atherosclerosis. 2004 Nov;177(1):203-10.
PMID: 15488885 [PubMed - indexed for MEDLINE]
Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
Taniguchi S, Yanase T, Kobayashi K, Takayanagi R, Haji M, Umeda F, Nawata H.
Endocr J. 1994 Dec;41(6):605-11.
PMID: 7704084 [PubMed - indexed for MEDLINE]
Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation.
Hwang J, Peterson H, Hodis HN, Choi B, Sevanian A.
Atherosclerosis. 2000 Jun;150(2):275-84.
PMID: 10856519 [PubMed - indexed for MEDLINE]
Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
Proc Soc Exp Biol Med. 1998 Jan;217(1):6-16. Review.
PMID: 9421201 [PubMed - indexed for MEDLINE]
Evidence for the role of high density lipoproteins in mediating the antioxidant effect of estrogens.
Abplanalp W, Scheiber MD, Moon K, Kessel B, Liu JH, Subbiah MT.
Eur J Endocrinol. 2000 Jan;142(1):79-83.
PMID: 10633226 [PubMed - indexed for MEDLINE]
Related Articles Free article at journal site
Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.
Zhang Y, Bhavnani BR.
BMC Neurosci. 2005 Feb 24;6:13.
PMID: 15730564 [PubMed - indexed for MEDLINE]
Antioxidant protection of lipoproteins containing estrogens: in vitro evidence for low- and high-density lipoproteins as estrogen carriers.
Meng QH, Höckerstedt A, Heinonen S, Wähälä K, Adlercreutz H, Tikkanen MJ.
Biochim Biophys Acta. 1999 Aug 18;1439(3):331-40.
PMID: 10446421 [PubMed - indexed for MEDLINE]
Is elevated high-density lipoprotein cholesterol always good for coronary heart disease?
Sun Y, Yang Y, Pei W, Wu Y, Zhao J.
Clin Cardiol. 2007 Nov;30(11):576-80.
PMID: 18000966 [PubMed - indexed for MEDLINE]
Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death.
Zhang Y, Lu X, Bhavnani BR.
BMC Neurosci. 2003 Dec 23;4:32.
PMID: 14693041 [PubMed - indexed for MEDLINE]
Effect of the combination of methyltestosterone and esterified estrogens compared with esterified estrogens alone on apolipoprotein CIII and other apolipoproteins in very low density, low density, and high density lipoproteins in surgically postmenopausal women.
Chiuve SE, Martin LA, Campos H, Sacks FM.
J Clin Endocrinol Metab. 2004 May;89(5):2207-13.
PMID: 15126543 [PubMed - indexed for MEDLINE]
Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
Evans M, Roberts A, Davies S, Rees A.
Drugs. 2004;64(11):1181-96. Review.
PMID: 15161326 [PubMed - indexed for MEDLINE]
Structure activity relationships and differential interactions and functional activity of various equine estrogens mediated via estrogen receptors (ERs) ERalpha and ERbeta.
Bhavnani BR, Tam SP, Lu X.
Endocrinology. 2008 Oct;149(10):4857-70. Epub 2008 Jul 3.
PMID: 18599548 [PubMed - indexed for MEDLINE]
Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.
Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM.
Am J Cardiol. 2006 Nov 15;98(10):1363-8. Epub 2006 Sep 29.
PMID: 17134630 [PubMed - indexed for MEDLINE]
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.
Circulation. 2005 Nov 29;112(22):3375-83.
PMID: 16316964 [PubMed - indexed for MEDLINE]
Inhibition of low-density lipoprotein and high-density lipoprotein oxidation by raloxifene.
Resch U, Mellauner V, Budinsky A, Sinzinger H.
J Womens Health (Larchmt). 2004 May;13(4):404-11.
PMID: 15186657 [PubMed - indexed for MEDLINE]